Principal Investigator
Dickran Kazandjian
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230236
Clinical Trial Summary
IMMUNOPLANT: Immuno-consolidation for newly diagnosed Multiple Myeloma Using lack of MRD Negativity after initial cOmbination therapy to Pursue deeper responses with Linvoseltamab ANd delay Transplant
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Myeloma
Contact Information
Phone Number
305-243-2647